Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians.
Saved in:
Main Authors: | DE Moulin, A Boulanger, AJ Clark, H Clarke, T Dao, GA Finley, A Furlan, I Gilron, A Gordon, PK Morley-Forster, BJ Sessle, P Squire, J Stinson, P Taenzer, A Velly, MA Ware, EL Weinberg, OD Williamson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2014/754693 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Management of Chronic Neuropathic Pain – Consensus Statement and Guidelines from the Canadian Pain Society
by: DE Moulin, et al.
Published: (2007-01-01) -
Use of Methadone for Neuropathic Pain
by: Dwight Moulin
Published: (2003-01-01) -
Gabapentin and Pregabalin for the Treatment of Neuropathic Pain: A Review of Laboratory and Clinical Evidence
by: Ian Gilron, et al.
Published: (2006-01-01) -
Maladaptive Plasticity and Neuropathic Pain
by: Xiang-Yao Li, et al.
Published: (2016-01-01) -
Methadone in the Treatment of Neuropathic Pain
by: Bruno Gagnon, et al.
Published: (2003-01-01)